WOLFGANG GEORG KONRAD MÜLLER-LIERHEIM,GYSBERT-BOTHO VAN SETTEN
申请号：
US16341915
公开号：
US20190240251A1
申请日:
2017.10.02
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention concerns a method for reducing or delaying the onset of irritation, discomfort, inflammation (acute or chronic), and/or an immune response at the ocular surface by topically administering a fluid comprising high molecular weight hyaluronic acid to the ocular surface of the eye of a human or non-human animal subject, wherein the hyaluronic acid has an intrinsic viscosity of >；2.5 m3/hg and a concentration of <；0.2% w/v.
